Coapt, LLC

Coapt manufactures Complete Control, an advanced myoelectric pattern recognition control system for upper limb prostheses. The Gen2 system is an intent decoder module that uses machine-learning algorithms to decode natural muscle signal patterns, enabling users with upper limb amputation or congenital limb difference to control prosthetic devices with unprecedented intuitiveness and naturalness. The technology works with most commercially available upper limb myoelectric prosthesis components, including transhumeral and transradial devices. Unlike traditional myoelectric prosthetic controllers that require precise, practiced inputs, Complete Control learns and adapts to individual users' muscle movement patterns through a calibration process, eliminating the need for device removal during adjustments. The system connects wirelessly to a mobile app for personalization fine-tuning. Coapt's technology represents a significant advancement in prosthetic control, reducing the cognitive burden on users and making prostheses function as natural extensions of the body rather than machines requiring careful input. The company has secured new CMS coding for upper-limb pattern recognition prostheses and is the subject of acquisition by Hanger, a major prosthetics and orthotics provider.